H

ello, everyone, and how are you today? We are just fine, thank you, now that the Pharmalot campus has settled down a bit. The shortest person has departed for the local schoolhouse and the official mascots are happily snoozing away. As for us, we are foraging, as always, for interesting items and digging in for another busy day. No doubt, you can relate. So time to get cracking. Here are some tidbits to help you along. Hope your day goes well and do stay in touch …

As generic competition nears for its Advair treatment for asthma and chronic obstructive pulmonary disease, GlaxoSmithKline has been making payers an “exploding offer” of a 20 percent or more discount, according to Bernstein analyst Ronny Gal. The deals cover all of 2017, he adds. As a result, he believes market prices may not drop sharply once generics arrive as some have expected.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of news in health and medicine.